Even as weight-loss drugs such as Wegovy and Zepbound explode in popularity, many Americans struggle to afford them.

More than 7 million Americans struggling with obesity would become eligible for coverage under the proposed change ...

It's uncertain whether the Biden administration proposal to cover obesity drugs in Medicare and Medicaid will survive ...

The Food and Drug Administration told a federal judge Thursday that it needs more time to reconsider whether Eli Lilly’s ...

Dear S.R.: Tirzepatide (Zepbound), like semaglutide, is a prescription medication originally used for diabetes but now ...

This is a prescription medication originally used for diabetes but now approved for weight loss. Most people regained weight ...

The outgoing Biden administration is proposing to have popular weight-loss drugs like Wegovy or Zepbound covered by Medicare ...

The Biden administration is proposing a major expansion of how Medicare and Medicaid cover the weight-loss drugs Wegovy and ...

The market didn't appreciate Amgen 's ( AMGN 1.00%) latest clinical data update, with the biopharma's shares falling more ...

Pharmaceutical stocks make great additions to any portfolio in any market environment. A good one promises steady revenue ...

Millions of obese Americans would get access to popular weekly injectables that would help them shed pounds quickly if a $35 ...

My husband and I have started taking Zepbound for various medical reasons. The medication has significantly and positively ...